Possible involvement of the hypothalamic pro-opiomelanocortin gene and β-endorphin expression on acute morphine withdrawal development

Brain Research Bulletin

Volumn 80, Issue 6, 2009, Pages 359-370

  Seo, Young Jun ^a   Kwon, Min Soo ^b   Choi, Seung Min ^c   Lee, Jin Koo ^c   Park, Soo Hyun ^c   Jung, Jun Sub ^c   Sim, Yun Beom ^c   Suh, Hong Won ^c  

^a Korea Food and Drug Administration   (South Korea)

^b Aero Technology Research Institute   (South Korea)

^c Hallym University   (South Korea)

Author keywords

Endorphin; Baclofen; Morphine withdrawal; Muscimol; Naloxone; Pro opiomelanocortin

Indexed keywords

BACLOFEN; BETA ENDORPHIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; I KAPPA B; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MORPHINE; MUSCIMOL; NALOXONE; PROOPIOMELANOCORTIN; PROTEIN C FOS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GABAERGIC TRANSMISSION; GENE EXPRESSION REGULATION; HYPOTHALAMUS; MALE; MOUSE; NONHUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; WITHDRAWAL SYNDROME;

ANIMALS; ARCUATE NUCLEUS; BACLOFEN; BETA-ENDORPHIN; DOSE-RESPONSE RELATIONSHIP, DRUG; GABA AGONISTS; GENE EXPRESSION; HYPOTHALAMUS; MALE; MICE; MICE, INBRED ICR; MORPHINE; MUSCIMOL; NALTREXONE; NARCOTIC ANTAGONISTS; NARCOTICS; PRO-OPIOMELANOCORTIN; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 70349972113     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2009.08.020     Document Type: Article

References (61)

1. Ammon-Treiber S., and Hollt V. Morphine-induced changes of gene expression in the brain. Addict. Biol. 10 (2005) 81-89
2. Baker R.A., and Shoemaker W.J. Effect of prenatal ethanol and stress on levels of beta-endorphin in different brain regions of the rat. Alcohol. Clin. Exp. Res. 19 (1995) 727-734
3. Bals-Kubik R., Ableitner A., Herz A., and Shippenberg T.S. Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. J. Pharmacol. Exp. Ther. 264 (1993) 489-495
4. Bloom F., Battenberg E., Rossier J., Ling N., and Guillemin R. Neurons containing beta-endorphin in rat brain exist separately from those containing enkephalin: immunocytochemical studies. Proc. Natl. Acad. Sci. U.S.A. 75 (1978) 1591-1595
5. Boutillier A.L., Gaiddon C., Lorang D., Roberts J.L., and Loeffler J.P. Transcriptional activation of the proopiomelanocortin gene by cyclic AMP-responsive element binding protein. Pituitary 1 (1998) 33-43
6. Boutillier A.L., Monnier D., Lorang D., Lundblad J.R., Roberts J.L., and Loeffler J.P. Corticotropin-releasing hormone stimulates proopiomelanocortin transcription by cFos-dependent and -independent pathways: characterization of an AP1 site in exon 1. Mol. Endocrinol. 9 (1995) 745-755
7. Bronstein D.M., Przewlocki R., and Akil H. Effects of morphine treatment on pro-opiomelanocortin systems in rat brain. Brain Res. 519 (1990) 102-111
8. Bronstein D.M., Schafer M.K., Watson S.J., and Akil H. Evidence that beta-endorphin is synthesized in cells in the nucleus tractus solitarius: detection of POMC mRNA. Brain Res. 587 (1992) 269-275
9. Calogero A.E., Gallucci W.T., Chrousos G.P., and Gold P.W. Interaction between GABAergic neurotransmission and rat hypothalamic corticotropin-releasing hormone secretion in vitro. Brain Res. 463 (1988) 28-36
10. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162 (1987) 156-159
11. Civelli O., Birnberg N., and Herbert E. Detection and quantitation of pro-opiomelanocortin mRNA in pituitary and brain tissues from different species. J. Biol. Chem. 257 (1982) 6783-6787
12. Danielson P.E., Forss-Petter S., Brow M.A., Calavetta L., Douglass J., Milner R.J., and Sutcliffe J.G. p1B15: a cDNA clone of the rat mRNA encoding cyclophilin. DNA 7 (1988) 261-267
13. Dash P.K., Karl K.A., Colicos M.A., Prywes R., and Kandel E.R. cAMP response element-binding protein is activated by Ca2+/calmodulin- as well as cAMP-dependent protein kinase. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 5061-5065
14. Dave J.R., Eiden L.E., Lozovsky D., Waschek J.A., and Eskay R.L. Calcium-independent and calcium-dependent mechanisms regulate corticotropin-releasing factor-stimulated proopiomelanocortin peptide secretion and messenger ribonucleic acid production. Endocrinology 120 (1987) 305-310
15. De Wied D., and Jolles J. Neuropeptides derived from pro-opiocortin: behavioral, physiological, and neurochemical effects. Physiol. Rev. 62 (1982) 976-1059
16. Deisseroth K., Bito H., and Tsien R.W. Signaling from synapse to nucleus: postsynaptic CREB phosphorylation during multiple forms of hippocampal synaptic plasticity. Neuron 16 (1996) 89-101
17. El-Kadi A.O., and Sharif S.I. Modification by muscimol of naloxone-precipitated withdrawal symptoms in morphine-dependent mice. Gen. Pharmacol. 26 (1995) 1579-1581
18. Fang Y., Kelly M.J., and Ronnekleiv O.K. Proopiomelanocortin (POMC) mRNA expression: distribution and region-specific down-regulation by chronic morphine in female guinea pig hypothalamus. Brain Res. Mol. Brain Res. 55 (1998) 1-8
19. Finley J.C., Lindstrom P., and Petrusz P. Immunocytochemical localization of beta-endorphin-containing neurons in the rat brain. Neuroendocrinology 33 (1981) 28-42
20. Garcia de Yebenes E., and Pelletier G. Opioid regulation of proopiomelanocortin (POMC) gene expression in the rat brain as studied by in situ hybridization. Neuropeptides 25 (1993) 91-94
21. Gerrits M.A., Wiegant V.M., and Van Ree J.M. Endogenous opioids implicated in the dynamics of experimental drug addiction: an in vivo autoradiographic analysis. Neuroscience 89 (1999) 1219-1227
22. Gianoulakis C. Implications of endogenous opioids and dopamine in alcoholism: human and basic science studies. Alcohol Alcohol. (Oxford, Oxfordshire) 31 Suppl 1 (1996) 33-42
23. Gianoulakis C., Drouin J.N., Seidah N.G., Kalant H., and Chretien M. Effect of chronic morphine treatment on beta-endorphin biosynthesis by the rat neurointermediate lobe. Eur. J. Pharmacol. 72 (1981) 313-321
24. Haley T.J. Pharmacological effects produced by intracerebral administration of drugs of unrelated structure to conscious mice. Arch. Int. Pharmacodyn. Ther. 110 (1957) 239-244
25. Hudson P., Penschow J., Shine J., Ryan G., Niall H., and Coghlan J. Hybridization histochemistry: use of recombinant DNA as a "homing probe" for tissue localization of specific mRNA populations. Endocrinology 108 (1981) 353-356
26. Karalis K.P., Venihaki M., Zhao J., van Vlerken L.E., and Chandras C. NF-kappaB participates in the corticotropin-releasing, hormone-induced regulation of the pituitary proopiomelanocortin gene. J. Biol. Chem. 279 (2004) 10837-10840
27. Keim S.R., and Shekhar A. The effects of GABAA receptor blockade in the dorsomedial hypothalamic nucleus on corticotrophin (ACTH) and corticosterone secretion in male rats. Brain Res. 739 (1996) 46-51
28. Kest B., Hopkins E., Palmese C.A., Adler M., and Mogil J.S. Genetic variation in morphine analgesic tolerance: a survey of 11 inbred mouse strains. Pharmacol. Biochem. Behav. 73 (2002) 821-828
29. Kest B., Palmese C.A., Hopkins E., Adler M., and Juni A. Assessment of acute and chronic morphine dependence in male and female mice. Pharmacol. Biochem. Behav. 70 (2001) 149-156
30. Koob G.F. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol. Sci. 13 (1992) 177-184
31. Koob G.F., and Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24 (2001) 97-129
32. Kovacs G.L., Acsai L., Tihanyi A., and Telegdy G. Catecholamine utilization in distinct mouse brain nuclei during acute morphine treatment, morphine tolerance and withdrawal syndrome. Eur. J. Pharmacol. 93 (1983) 149-158
33. Kovalovsky D., Refojo D., Liberman A.C., Hochbaum D., Pereda M.P., Coso O.A., Stalla G.K., Holsboer F., and Arzt E. Activation and induction of NUR77/NURR1 in corticotrophs by CRH/cAMP: involvement of calcium, protein kinase A, and MAPK pathways. Mol. Endocrinol. 16 (2002) 1638-1651
34. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
35. Lamonerie T., Tremblay J.J., Lanctot C., Therrien M., Gauthier Y., and Drouin J. Ptx1, a bicoid-related homeo box transcription factor involved in transcription of the pro-opiomelanocortin gene. Genes Dev. 10 (1996) 1284-1295
36. Makara G.B., and Stark E. Effects of gamma-aminobutyric acid (GABA) and GABA antagonist drugs on ACTH release. Neuroendocrinology 16 (1974) 178-190
37. Nehmad R., Nadler H., and Simantov R. Effects of acute and chronic morphine treatment of calmodulin activity of rat brain. Mol. Pharmacol. 22 (1982) 389-394
38. Olive M.F., Koenig H.N., Nannini M.A., and Hodge C.W. Stimulation of endorphin neurotransmission in the nucleus accumbens by ethanol, cocaine, and amphetamine. J. Neurosci. 21 (2001) RC184
39. Philips A., Maira M., Mullick A., Chamberland M., Lesage S., Hugo P., and Drouin J. Antagonism between Nur77 and glucocorticoid receptor for control of transcription. Mol. Cell Biol. 17 (1997) 5952-5959
40. Ritzmann R.F. Opiate dependence following acute injections of morphine and naloxone: the assessment of various withdrawal signs. Pharmacol. Biochem. Behav. 14 (1981) 575-577
41. Seo Y.J., Kwon M.S., Choi S.S., Han E.J., Jung J.S., Choi H.W., Park S.H., Jang J.E., and Suh H.W. Characterization of the hypothalamic proopiomelanocortin gene and beta-endorphin expression in the hypothalamic arcuate nucleus of mice elicited by inflammatory pain. Neuroscience 152 (2008) 1054-1066
42. Skoubis P.D., Lam H.A., Shoblock J., Narayanan S., and Maidment N.T. Endogenous enkephalins, not endorphins, modulate basal hedonic state in mice. Eur. J. Neurosci. 21 (2005) 1379-1384
43. Spanagel R., and Weiss F. The dopamine hypothesis of reward: past and current status. Trends Neurosci. 22 (1999) 521-527
44. Suh H.W., Kim Y.H., Choi Y.S., Choi S.R., and Song D.K. Effects of GABA receptor antagonists injected spinally on antinociception induced by opioids administered supraspinally in mice. Eur. J. Pharmacol. 307 (1996) 141-147
45. Sun Y.G., Lundeberg T., and Yu L.C. Involvement of endogenous beta-endorphin in antinociception in the arcuate nucleus of hypothalamus in rats with inflammation. Pain 104 (2003) 55-63
46. Sweep C.G., Van Ree J.M., and Wiegant V.M. Characterization of beta-endorphin-immunoreactivity in limbic brain structures of rats self-administering heroin or cocaine. Neuropeptides 12 (1988) 229-236
47. Sweep C.G., Wiegant V.M., De Vry J., and Van Ree J.M. Beta-endorphin in brain limbic structures as neurochemical correlate of psychic dependence on drugs. Life Sci. 44 (1989) 1133-1140
48. Tang L., Shukla P.K., Wang L.X., and Wang Z.J. Reversal of morphine antinociceptive tolerance and dependence by the acute supraspinal inhibition of Ca(2+)/calmodulin-dependent protein kinase II. J. Pharmacol. Exp. Ther. 317 (2006) 901-909
49. Therrien M., and Drouin J. Pituitary pro-opiomelanocortin gene expression requires synergistic interactions of several regulatory elements. Mol. Cell Biol. 11 (1991) 3492-3503
50. Towbin H., Staehelin T., and Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U.S.A. 76 (1979) 4350-4354
51. Tseng L.F. Evidence for epsilon-opioid receptor-mediated beta-endorphin-induced analgesia. Trends Pharmacol. Sci. 22 (2001) 623-630
52. Tsuda M. Cascade of gene expression induced by Ca2+ signals in neurons. Neurochem. Int. 29 (1996) 443-451
53. Turchan J., Przewlocka B., Toth G., Lason W., Borsodi A., and Przewlocki R. The effect of repeated administration of morphine, cocaine and ethanol on mu and delta opioid receptor density in the nucleus accumbens and striatum of the rat. Neuroscience 91 (1999) 971-977
54. Van Ree J.M. Endorphins and experimental addiction. Alcohol (Fayetteville, N.Y.) 13 (1996) 25-30
55. Van Ree J.M., Smyth D.G., and Colpaert F.C. Dependence creating properties of lipotropin C-fragment (beta-endorphin): evidence for its internal control of behavior. Life Sci. 24 (1979) 495-502
56. Wardlaw S.L., Kim J., and Sobieszczyk S. Effect of morphine on proopiomelanocortin gene expression and peptide levels in the hypothalamus. Brain Res. Mol. Brain Res. 41 (1996) 140-147
57. Xiang Y., Gao H., Zhu H., Sun N., Ma Y., and Lei H. Neurochemical changes in brain induced by chronic morphine treatment: NMR studies in thalamus and somatosensory cortex of rats. Neurochem. Res. 31 (2006) 1255-1261
58. Xing J., Ginty D.D., and Greenberg M.E. Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science 273 (1996) 959-963
59. Yamamoto H., Harris R.A., Loh H.H., and Way E.L. Effects of acute and chronic morphine treatments on calcium localization and binding in brain. J. Pharmacol. Exp. Ther. 205 (1978) 255-264
60. Zarrindast M.R., and Mousa-Ahmadi E. Effects of GABAergic system on naloxone-induced jumping in morphine-dependent mice. Eur. J. Pharmacol. 381 (1999) 129-133
61. Zhang G., Lagrange A.H., Ronnekleiv O.K., and Kelly M.J. Tolerance of hypothalamic beta-endorphin neurons to mu-opioid receptor activation after chronic morphine. J. Pharmacol. Exp. Ther. 277 (1996) 551-558